Measuring Omalizumab Responses Using Real-world Evidence (MORRE) Study
NCT04724278
·
clinicaltrials.gov ↗
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Asthma
Sponsor
National Jewish Health